DE69232878D1 - Zwischenprodukte zur Herstellung von 1-substituierten, 2-substituierten-1H-Imidazo[4,5-c]Chinolin-4-Aminen - Google Patents
Zwischenprodukte zur Herstellung von 1-substituierten, 2-substituierten-1H-Imidazo[4,5-c]Chinolin-4-AminenInfo
- Publication number
- DE69232878D1 DE69232878D1 DE69232878T DE69232878T DE69232878D1 DE 69232878 D1 DE69232878 D1 DE 69232878D1 DE 69232878 T DE69232878 T DE 69232878T DE 69232878 T DE69232878 T DE 69232878T DE 69232878 D1 DE69232878 D1 DE 69232878D1
- Authority
- DE
- Germany
- Prior art keywords
- substituted
- imidazo
- intermediates
- amines
- quinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Lubricants (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66292691A | 1991-03-01 | 1991-03-01 | |
US68732691A | 1991-04-18 | 1991-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69232878D1 true DE69232878D1 (de) | 2003-01-30 |
DE69232878T2 DE69232878T2 (de) | 2003-11-20 |
Family
ID=27098631
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69229114T Expired - Lifetime DE69229114T2 (de) | 1991-03-01 | 1992-02-20 | 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine |
DE69232878T Expired - Fee Related DE69232878T2 (de) | 1991-03-01 | 1992-02-20 | Zwischenprodukte zur Herstellung von 1-substituierten, 2-substituierten-1H-Imidazo[4,5-c]Chinolin-4-Aminen |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69229114T Expired - Lifetime DE69229114T2 (de) | 1991-03-01 | 1992-02-20 | 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP0582581B1 (de) |
JP (1) | JP2955019B2 (de) |
AT (2) | ATE179711T1 (de) |
AU (2) | AU658621B2 (de) |
CA (2) | CA2104782C (de) |
CZ (1) | CZ285050B6 (de) |
DE (2) | DE69229114T2 (de) |
DK (2) | DK0872478T3 (de) |
ES (2) | ES2186034T3 (de) |
HU (5) | HU222111B1 (de) |
IE (1) | IE920605A1 (de) |
IL (2) | IL114570A (de) |
NO (1) | NO303729B1 (de) |
NZ (1) | NZ241784A (de) |
PH (1) | PH31614A (de) |
SG (2) | SG46492A1 (de) |
UA (1) | UA32546C2 (de) |
WO (1) | WO1992015582A1 (de) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266575A (en) * | 1991-11-06 | 1993-11-30 | Minnesota Mining And Manufacturing Company | 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines |
US5395937A (en) * | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
US5648516A (en) * | 1994-07-20 | 1997-07-15 | Minnesota Mining And Manufacturing Company | Fused cycloalkylimidazopyridines |
US5352784A (en) * | 1993-07-15 | 1994-10-04 | Minnesota Mining And Manufacturing Company | Fused cycloalkylimidazopyridines |
JPH09500128A (ja) * | 1993-07-15 | 1997-01-07 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | イミダゾ〔4,5−c〕ピリジン−4−アミン |
US5482936A (en) * | 1995-01-12 | 1996-01-09 | Minnesota Mining And Manufacturing Company | Imidazo[4,5-C]quinoline amines |
US6133547A (en) * | 1996-09-05 | 2000-10-17 | Medtronic, Inc. | Distributed activator for a two-dimensional shape memory alloy |
US5939090A (en) * | 1996-12-03 | 1999-08-17 | 3M Innovative Properties Company | Gel formulations for topical drug delivery |
JPH10298181A (ja) * | 1997-04-25 | 1998-11-10 | Sumitomo Pharmaceut Co Ltd | タイプ2ヘルパーt細胞選択的免疫応答抑制剤 |
EP1541572A1 (de) * | 2000-12-08 | 2005-06-15 | 3M Innovative Properties Company | Thioether substituierte Imidazochinoline |
UA74852C2 (en) * | 2000-12-08 | 2006-02-15 | 3M Innovative Properties Co | Urea-substituted imidazoquinoline ethers |
US6664264B2 (en) * | 2000-12-08 | 2003-12-16 | 3M Innovative Properties Company | Thioether substituted imidazoquinolines |
GB0211649D0 (en) * | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
CN1315828C (zh) * | 2002-07-23 | 2007-05-16 | 特瓦药厂私人有限公司 | 通过1h-咪唑并[4,5-c]喹啉-4-邻苯二甲酰亚胺类中间体制备1h-咪唑并[4,5-c]喹啉-4-胺类化合物 |
JP5043435B2 (ja) | 2003-10-03 | 2012-10-10 | スリーエム イノベイティブ プロパティズ カンパニー | アルコキシ置換イミダゾキノリン |
AR046781A1 (es) | 2003-11-25 | 2005-12-21 | 3M Innovative Properties Co | Derivados de imidazoquinolinas. composiciones farmaceuticas. |
EP1765348B1 (de) * | 2004-06-18 | 2016-08-03 | 3M Innovative Properties Company | Substituierte imidazochinoline, imidazopyridine sowie imidazonaphthyridine |
US8080560B2 (en) | 2004-12-17 | 2011-12-20 | 3M Innovative Properties Company | Immune response modifier formulations containing oleic acid and methods |
WO2006084251A2 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune reponse modifiers |
SG164344A1 (en) | 2005-02-18 | 2010-09-29 | Novartis Vaccines & Diagnostics Srl | Immunogens from uropathogenic escherichia coli |
EP1858920B1 (de) | 2005-02-18 | 2016-02-03 | GlaxoSmithKline Biologicals SA | Proteine und nukleinsäuren von meningitis-/sepsis-assoziierten escherichia coli |
US8178677B2 (en) | 2005-02-23 | 2012-05-15 | 3M Innovative Properties Company | Hydroxyalkyl substituted imidazoquinolines |
JP2008531567A (ja) | 2005-02-23 | 2008-08-14 | コーリー ファーマシューティカル グループ,インコーポレイテッド | ヒドロキシアルキル置換イミダゾキノリン化合物および方法 |
AU2006216686A1 (en) | 2005-02-23 | 2006-08-31 | Coley Pharmaceutical Group, Inc. | Method of preferentially inducing the biosynthesis of interferon |
US7943636B2 (en) | 2005-04-01 | 2011-05-17 | 3M Innovative Properties Company | 1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
EP1945252B1 (de) | 2005-11-04 | 2013-05-29 | Novartis Vaccines and Diagnostics S.r.l. | Squalen adjuvans-impfstoff influenza oberflächen-antigene gereinigt aus in zellkulturen gezüchteten influenza-viren enthaltend |
CA2628206A1 (en) | 2005-11-04 | 2007-05-10 | Novartis Vaccines And Diagnostics S.R.L. | Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
JP5247458B2 (ja) * | 2005-11-04 | 2013-07-24 | スリーエム・イノベイティブ・プロパティーズ・カンパニー | ヒドロキシ及びアルコキシ置換1h−イミダゾキノリン及び方法 |
JP2009514839A (ja) | 2005-11-04 | 2009-04-09 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | サイトカイン誘導剤を含むアジュバントインフルエンザワクチン |
PT1951299E (pt) | 2005-11-04 | 2012-02-28 | Novartis Vaccines & Diagnostic | Vacinas contra a gripe que incluem combinações de adjuvantes particulados e imuno-potenciadores |
JP6087041B2 (ja) | 2006-01-27 | 2017-03-08 | ノバルティス アーゲー | 血球凝集素およびマトリックスタンパク質を含むインフルエンザウイルスワクチン |
WO2007110776A1 (en) | 2006-03-24 | 2007-10-04 | Novartis Vaccines And Diagnostics Gmbh & Co Kg | Storage of influenza vaccines without refrigeration |
EP2382988A1 (de) | 2006-03-31 | 2011-11-02 | Novartis AG | Kombinierte mukosale und parenterale Immunisierung gegen HIV |
ATE522541T1 (de) | 2006-06-09 | 2011-09-15 | Novartis Ag | Bakterielle adhäsine konformere |
GB0614460D0 (en) | 2006-07-20 | 2006-08-30 | Novartis Ag | Vaccines |
US8124096B2 (en) | 2006-07-31 | 2012-02-28 | 3M Innovative Properties Company | Immune response modifier compositions and methods |
EP2586790A3 (de) | 2006-08-16 | 2013-08-14 | Novartis AG | Immunogene von uropathogenen Escherichia coli |
ES2536401T3 (es) | 2006-09-11 | 2015-05-25 | Novartis Ag | Fabricación de vacunas contra virus de la gripe sin usar huevos |
ES2480491T3 (es) | 2006-12-06 | 2014-07-28 | Novartis Ag | Vacunas incluyendo antígeno de cuatro cepas de virus de la gripe |
GB0700562D0 (en) | 2007-01-11 | 2007-02-21 | Novartis Vaccines & Diagnostic | Modified Saccharides |
ES2393037T3 (es) * | 2007-05-08 | 2012-12-18 | Astrazeneca Ab | Imidazoquinolinas con propiedades inmunomoduladoras |
BRPI0813866A2 (pt) | 2007-06-27 | 2015-01-06 | Novartis Ag | Vacinas contra influenza com baixo teor de aditivos |
GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
GB0810305D0 (en) | 2008-06-05 | 2008-07-09 | Novartis Ag | Influenza vaccination |
GB0818453D0 (en) | 2008-10-08 | 2008-11-12 | Novartis Ag | Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
SI2268618T1 (sl) * | 2008-03-03 | 2015-09-30 | Novartis Ag | Spojine in sestavki kot modulatorji aktivnosti TLR |
JP5518041B2 (ja) | 2008-03-18 | 2014-06-11 | ノバルティス アーゲー | インフルエンザウイルスワクチン抗原の調製における改良 |
NZ599446A (en) * | 2008-03-24 | 2013-11-29 | 4Sc Discovery Gmbh | Novel substituted imidazoquinolines |
EP3549602A1 (de) | 2009-03-06 | 2019-10-09 | GlaxoSmithKline Biologicals S.A. | Chlamydia-antigene |
SI2510947T1 (sl) | 2009-04-14 | 2016-05-31 | Glaxosmithkline Biologicals S.A. | Sestavki za imunizacijo proti Staphylococcus aureus |
KR20120027276A (ko) | 2009-04-27 | 2012-03-21 | 노파르티스 아게 | 인플루엔자를 예방하기 위한 면역증강된 백신 |
CA2767536A1 (en) | 2009-07-07 | 2011-01-13 | Novartis Ag | Conserved escherichia coli immunogens |
BR112012001666A2 (pt) | 2009-07-15 | 2019-09-24 | Novartis Ag | composições de proteína rsv f e métodos para fazer as mesmas |
JP2012532626A (ja) | 2009-07-16 | 2012-12-20 | ノバルティス アーゲー | 無毒化されたEscherichiacoli免疫原 |
GB0918392D0 (en) | 2009-10-20 | 2009-12-02 | Novartis Ag | Diagnostic and therapeutic methods |
GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
WO2011084726A1 (en) * | 2009-12-21 | 2011-07-14 | 3M Innovative Properties Company | BIS [4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM] 4-[(3-CARBOXYLATO-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
WO2011084725A1 (en) * | 2009-12-21 | 2011-07-14 | 3M Innovative Properties Company | 4-AMINO-2-(ETHOXYMETHYL)-1-(2-HYDROXY-2-METHYLPROPYL)-1H-IMIDAZO[4,5-c]QUINOLIN-5-IUM 1-HYDROXYNAPHTHALENE-2-CARBOXYLATE COMPOSITIONS AND METHODS |
ES2707778T3 (es) | 2009-12-30 | 2019-04-05 | Glaxosmithkline Biologicals Sa | Inmunógenos polisacáridos conjugados con proteínas portadoras de E. coli |
AU2011258156B2 (en) | 2010-05-26 | 2016-11-24 | Selecta Biosciences, Inc. | Multivalent synthetic nanocarrier vaccines |
ES2825712T3 (es) | 2010-06-01 | 2021-05-17 | Seqirus Uk Ltd | Concentración de antígenos de vacuna contra la influenza sin liofilización |
PT2575873E (pt) | 2010-06-01 | 2016-03-04 | Novartis Ag | Concentração de antigénios de vacinas com liofilização |
GB201009861D0 (en) | 2010-06-11 | 2010-07-21 | Novartis Ag | OMV vaccines |
ES2531577T3 (es) | 2010-08-20 | 2015-03-17 | Novartis Ag | Conjuntos de agujas para la administración de vacuna soluble contra la gripe |
US9994443B2 (en) | 2010-11-05 | 2018-06-12 | Selecta Biosciences, Inc. | Modified nicotinic compounds and related methods |
SI2667892T1 (sl) | 2011-01-26 | 2019-05-31 | Glaxosmithkline Biologicals Sa | Imunizacijski režim proti RSV |
ES2651143T3 (es) | 2011-05-13 | 2018-01-24 | Glaxosmithkline Biologicals Sa | Antígenos de F de prefusión del VRS |
US8728486B2 (en) | 2011-05-18 | 2014-05-20 | University Of Kansas | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds |
US9149541B2 (en) | 2011-07-08 | 2015-10-06 | Novartis Ag | Tyrosine ligation process |
CN104080479B (zh) | 2011-11-07 | 2019-11-05 | 葛兰素史密丝克莱恩生物有限公司 | 包括spr0096和spr2021抗原的运载体分子 |
WO2013108272A2 (en) | 2012-01-20 | 2013-07-25 | International Centre For Genetic Engineering And Biotechnology | Blood stage malaria vaccine |
WO2014053521A2 (en) | 2012-10-02 | 2014-04-10 | Novartis Ag | Nonlinear saccharide conjugates |
CN111249455A (zh) | 2012-11-30 | 2020-06-09 | 葛兰素史密丝克莱恩生物有限公司 | 假单胞菌抗原和抗原组合 |
EP3632426A1 (de) | 2013-02-01 | 2020-04-08 | Wellstat Therapeutics Corporation | Aminverbindungen mit entzündungshemmender, fungizider, antiparasitärer und antikrebswirkung |
EP2870974A1 (de) | 2013-11-08 | 2015-05-13 | Novartis AG | Salmonella-Konjugatimpfstoffe |
ES2769647T3 (es) | 2014-03-26 | 2020-06-26 | Glaxosmithkline Biologicals Sa | Antígenos estafilocócicos mutantes |
AR100137A1 (es) * | 2014-04-22 | 2016-09-14 | Hoffmann La Roche | Compuestos 4-amino-imidazoquinolina |
CN107295798B (zh) | 2015-03-06 | 2020-10-30 | 豪夫迈·罗氏有限公司 | 苯并氮杂*二甲酰胺化合物 |
AU2016322813B2 (en) * | 2015-09-14 | 2021-04-01 | Pfizer Inc. | Novel imidazo (4,5-c) quinoline and imidazo (4,5-c)(1,5) naphthyridine derivatives as LRRK2 inhibitors |
WO2017046112A1 (en) | 2015-09-17 | 2017-03-23 | F. Hoffmann-La Roche Ag | Sulfinylphenyl or sulfonimidoylphenyl benzazepines |
JP7022702B2 (ja) | 2016-05-23 | 2022-02-18 | エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト | 第二級アミド基を有するベンズアゼピンジカルボキサミド化合物 |
CN109153648B (zh) | 2016-05-23 | 2022-07-22 | 豪夫迈·罗氏有限公司 | 具有叔酰胺官能团的苯并氮杂卓二甲酰胺化合物 |
EP3468963B1 (de) | 2016-06-12 | 2021-10-27 | F. Hoffmann-La Roche AG | Dihydropyrimidinyl-benzazepincarboxamide verbindungen |
TWI674261B (zh) * | 2017-02-17 | 2019-10-11 | 美商英能腫瘤免疫股份有限公司 | Nlrp3 調節劑 |
BR112019024177A2 (pt) * | 2017-05-19 | 2020-06-02 | Superb Wisdom Limited | Derivados de resiquimode |
BR112019027025A2 (pt) * | 2017-06-23 | 2020-06-30 | Birdie Biopharmaceuticals, Inc. | composições farmacêuticas |
US20220305115A1 (en) | 2019-06-18 | 2022-09-29 | Janssen Sciences Ireland Unlimited Company | Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL73534A (en) * | 1983-11-18 | 1990-12-23 | Riker Laboratories Inc | 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds |
CA1271477A (en) * | 1983-11-18 | 1990-07-10 | John F. Gerster | 1h-imidazo[4,5-c]quinolin-4-amines |
DK0385630T3 (da) * | 1989-02-27 | 1997-05-12 | Riker Laboratories Inc | 1H-imidazo(4,5-c)quinolin-4-aminer som antivirale midler |
-
1992
- 1992-02-20 DK DK98105754T patent/DK0872478T3/da active
- 1992-02-20 DE DE69229114T patent/DE69229114T2/de not_active Expired - Lifetime
- 1992-02-20 ES ES98105754T patent/ES2186034T3/es not_active Expired - Lifetime
- 1992-02-20 HU HU9302457A patent/HU222111B1/hu not_active IP Right Cessation
- 1992-02-20 DK DK92906763T patent/DK0582581T3/da active
- 1992-02-20 SG SG1996005108A patent/SG46492A1/en unknown
- 1992-02-20 CA CA002104782A patent/CA2104782C/en not_active Expired - Lifetime
- 1992-02-20 AT AT92906763T patent/ATE179711T1/de not_active IP Right Cessation
- 1992-02-20 HU HU9701083A patent/HU222247B1/hu not_active IP Right Cessation
- 1992-02-20 HU HU9701089A patent/HU222250B1/hu not_active IP Right Cessation
- 1992-02-20 SG SG1998000326A patent/SG70625A1/en unknown
- 1992-02-20 AT AT98105754T patent/ATE229943T1/de not_active IP Right Cessation
- 1992-02-20 EP EP92906763A patent/EP0582581B1/de not_active Expired - Lifetime
- 1992-02-20 CZ CZ931788A patent/CZ285050B6/cs not_active IP Right Cessation
- 1992-02-20 WO PCT/US1992/001305 patent/WO1992015582A1/en active IP Right Grant
- 1992-02-20 UA UA94020490A patent/UA32546C2/uk unknown
- 1992-02-20 AU AU15669/92A patent/AU658621B2/en not_active Expired
- 1992-02-20 HU HU9701084A patent/HU222251B1/hu not_active IP Right Cessation
- 1992-02-20 DE DE69232878T patent/DE69232878T2/de not_active Expired - Fee Related
- 1992-02-20 CA CA002289219A patent/CA2289219C/en not_active Expired - Lifetime
- 1992-02-20 ES ES92906763T patent/ES2131070T3/es not_active Expired - Lifetime
- 1992-02-20 EP EP98105754A patent/EP0872478B1/de not_active Expired - Lifetime
- 1992-02-20 JP JP4506455A patent/JP2955019B2/ja not_active Expired - Lifetime
- 1992-02-26 IE IE060592A patent/IE920605A1/en not_active IP Right Cessation
- 1992-02-28 NZ NZ241784A patent/NZ241784A/en not_active IP Right Cessation
- 1992-02-28 PH PH43994A patent/PH31614A/en unknown
- 1992-03-01 IL IL11457092A patent/IL114570A/en not_active IP Right Cessation
- 1992-03-01 IL IL10111092A patent/IL101110A/en not_active IP Right Cessation
-
1993
- 1993-08-27 NO NO933069A patent/NO303729B1/no not_active IP Right Cessation
-
1995
- 1995-07-03 HU HU95P/P00753P patent/HU211242A9/hu unknown
- 1995-07-25 AU AU27157/95A patent/AU673309B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69232878D1 (de) | Zwischenprodukte zur Herstellung von 1-substituierten, 2-substituierten-1H-Imidazo[4,5-c]Chinolin-4-Aminen | |
NO304946B1 (no) | Xantinderivat samt dets anvendelse | |
ATE250606T1 (de) | Purinderivate und ihre anwendung als anticoagulante | |
ES2163478T3 (es) | Procedimiento de preparacion de composiciones cosmeticas o farmaceuticas que contienen liposomas. | |
AU6947401A (en) | Phenylpyridazine derivatives and drugs containing the same | |
IL88303A (en) | Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
ES2063452T3 (es) | Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos. | |
ATE109763T1 (de) | Benzophenon-derivate. | |
IL106147A0 (en) | 4-iminoquinolines,processes for their preparation,and their use | |
ATE203537T1 (de) | Pyrazol(1,5-a)pyrimidin derivate | |
TR200003877T2 (tr) | İnsan CD23 üretiminin ve TNF salınmasının ihhibitörleri olan hiydroxamic acid türevleri | |
IE890293L (en) | Quinolone derivatives | |
EP0440324A3 (en) | Substituted beta-diketones and their use | |
ATE139767T1 (de) | Verfahren zur herstellung 5-pyrazolomerkaptan- derivate und dessen zwischenprodukte | |
PT87954A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico | |
DE69218718T2 (de) | Pharmazeutische Zusammensetzungen die Triazole Derivate enthalten zur rektalen Verabbrechung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |